Personalized mRNA vaccine lowers melanoma risk

Merck and Moderna’s experimental mRNA vaccine cut the risk melanoma returned by 42%, opening a door for a new way to treat cancer. CNN’s Meg Tirrell reports.
Source: CNN ↗ · 2026-10-26 · Official embed (owner allows embedding) · kind: news
Played through the owner's official player or file host; Banana News does not host or copy the video.





